연구동향 분석

Invited Mini Review : Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson`s disease and beyond

( Jae Ryul Bae ) ( Byoung Dae Lee ) 2015년

논문상세정보
인용/피인용
' Invited Mini Review : Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson`s disease and beyond' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 생물학
  • ad
  • alzheimers disease
  • cd
  • crohnsdisease
  • leucinerichrepeatkinase2
  • lrrk2
  • parkinsons disease
  • pd
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
760 0

0.0%

' Invited Mini Review : Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson`s disease and beyond' 의 참고문헌

  • eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation
    Gingras AC Annu Rev Biochem 68 : 913 ~ 963 [1999]
  • Unravelling the pathogenesis of inflammatory bowel disease
    Xavier RJ Nature 448 : 427 ~ 434 [2007]
  • Uncoordinated regulation of stress fibers and focal adhesions by DAP kinase
    Kuo JC J Cell Sci 116 : 4777 ~ 4790 [2003]
  • Tumor suppressor death-associated protein kinase is required for full IL-1beta production
    Chuang YT Blood 117 : 960 ~ 970 [2011]
  • The tumor suppressor death-associated protein kinase targets to TCR-stimulated NF-kappa B activation
    Chuang YT J Immunol 180 : 3238 ~ 3249 [2008]
  • The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway
    Kuo JC J Cell Biol 172 : 619 ~ 631 [2006]
  • The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD
    Parkinson Study G Neurology 62 : 330 ~ 332 [2004]
  • The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
    Liu Z Nat Immunol 12 : 1063 ~ 1070 [2011]
  • The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease
    Linnertz C Hum Mol Genet 23 : 4814 ~ 4821 [2014]
  • The familial Parkinsonism gene LRRK2 regulates neurite process morphology
    MacLeod D Neuron 52 : 587 ~ 593 [2006]
  • The death-associated protein kinases: structure, function, and beyond
    Bialik S Annu Rev Biochem 75 : 189 ~ 210 [2006]
  • The RIP kinases: crucial integrators of cellular stress
    Meylan E Trends Biochem Sci 30 : 151 ~ 159 [2005]
  • The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
    Inzelberg R Neurology 78 : 781 ~ 786 [2012]
  • The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling
    Dzamko N PLoS One 7 : e39132 ~ [2012]
  • Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning
    Dodson MW Hum Mol Genet 21 : 1350 ~ 1363 [2012]
  • Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease
    Martin I Cell 157 : 472 ~ 485 [2014]
  • Regulation of LRRK2 expression points to a functional role in human monocyte maturation
    Thevenet J PLoS One 6 : e21519 ~ [2011]
  • Receptor-interacting protein(RIP)kinase family
    Zhang D Cell Mol Immunol 7 : 243 ~ 249 [2010]
  • R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
    Tong Y Proc Natl Acad Sci U S A 106 : 14622 ~ 14627 [1441]
  • Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
    Gehrke S Nature 466 : 637 ~ 641 [2010]
  • Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
    Hakimi M J Neural Transm 118 : 795 ~ 808 [2011]
  • Parkinson's disease and cancer: two wars, one front
    Devine MJ Nat Rev Cancer 11 : 812 ~ 823 [2011]
  • Non-Abeta component of Alzheimer's disease amyloid(NAC)revisited. NAC and alpha-synuclein are not associated with Abeta amyloid
    Culvenor JG Am J Pathol 155 : 1173 ~ 1181 [1999]
  • Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
    Zimprich A Neuron 44 : 601 ~ 607 [2004]
  • Mutant LRRK2(R1441G)BAC transgenic mice recapitulate cardinal features of Parkinson's disease
    Li Y Nat Neurosci 12 : 826 ~ 828 [1441]
  • Mixedlineage kinases: a target for the prevention of neurodegeneration
    Wang LH Annu Rev Pharmacol Toxicol 44 : 451 ~ 474 [2004]
  • Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice
    Boyle, S. Giaime, E. Kelleher, R.J. Kopan, R. Shen, J. Tong Y Yamaguchi, H. Proc Natl Acad Sci U S A 107 : 9879 ~ 9884 [2010]
  • Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway
    Tong Y Mol Neurodegener 7 : 2 ~ [2012]
  • Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein
    Lin X Neuron 64 : 807 ~ 827 [2009]
  • Lethal weapons: DAP-kinase, autophagy and cell death: DAP-kinase regulates autophagy
    Bialik S Curr Opin Cell Biol 22 : 199 ~ 205 [2010]
  • LRRK2controls an EndoA phosphorylation cycle in synaptic endocytosis
    Matta S Neuron 75 : 1008 ~ 1021 [2012]
  • LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
    Parisiadou L Nat Neurosci 17 : 367 ~ 376 [2014]
  • LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model
    Alegre-Abarrategui J Hum Mol Genet 18 : 4022 ~ 4034 [2009]
  • LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
    Herzig MC Hum Mol Genet 20 : 4209 ~ 4223 [2011]
  • LRRK2 phosphorylates tubulin-associated tau but not the free molecule:LRRK2-mediated regulation of the tau-tubulin association and neurite outgrowth
    Kawakami F PLoS One 7 : e30834 ~ [2012]
  • LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction
    Lee S J Neurosci 30 : 16959 ~ 16969 [2010]
  • LRRK2 is involved in the IFN-gamma response and host response to pathogens
    Gardet A J Immunol 185 : 5577 ~ 5585 [2010]
  • LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD
    Chen CY Cell Death Differ 19 : 1623 ~ 1633 [2012]
  • LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease
    Saunders-Pullman R Mov Disord 25 : 2536 ~ 2541 [2010]
  • Higher Frequency of Certain Cancers in LRRK2 G2019S Mutation Carriers With Parkinson Disease: A Pooled Analysis
    Agalliu I JAMA Neurol 72 : 58 ~ 65 [2015]
  • Genomewide association study of leprosy
    Zhang FR N Engl J Med 361 : 2609 ~ 2618 [2009]
  • Genomewide association defines more than 30 distinct susceptibility loci for Crohn's disease
    Barrett JC Nat Genet 40 : 955 ~ 962 [2008]
  • Function of Nod-like receptors in microbial recognition and host defense
    Franchi L Immunol Rev 227 : 106 ~ 128 [2009]
  • Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition
    Hockey LN J Cell Sci 128 : 232 ~ 238 [2015]
  • Distinct alpha-synuclein strains differentially promote tau inclusions in neurons
    Guo JL Cell 154 : 103 ~ 117 [2013]
  • Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
    Fuss IJ J Immunol 157 : 1261 ~ 1270 [1996]
  • Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
    Sanchez-Danes A EMBO Mol Med 4 : 380 ~ 395 [2012]
  • Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
    Paisan-Ruiz C Neuron 44 : 595 ~ 600 [2004]
  • Chromosomal amplification of leucine-rich repeat kinase-2(LRRK2)is required for oncogenic MET signaling in papillary renal and thyroid carcinomas
  • Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk
    Moskvina V JAMA Neurol 70 : 1268 ~ 1276 [2013]
  • An LRRK2mutation as a cause for the parkinsonism in the original PARK8 family
    Funayama M Ann Neurol 57 : 918 ~ 921 [2005]
  • Altered serum IgG levels to alpha-synuclein in dementia with Lewy bodies and Alzheimer's disease
    Koehler NK PLoS One 8 : e64649 ~ [2013]
  • Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction(RT-PCR)
    Niessner M Clin Exp Immunol 101 : 428 ~ 435 [1995]
  • Alpha-synuclein, Parkinson's disease, and Alzheimer's disease
    Kim S Parkinsonism Relat Disord 10 (1) : 9 ~ 13 [2004]
  • Active, phosphorylation-dependent mitogen-activated protein kinase(MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase(SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies
    Ferrer I J Neural Transm 108 : 1383 ~ 1396 [2001]
  • Activation and regulation of Toll-like receptors 2 and 1 in human leprosy
    Krutzik SR Nat Med 9 : 525 ~ 532 [2003]
  • A Drosophila model for LRRK2-linked parkinsonism
    Liu Z Proc Natl Acad Sci U S A 105 : 2693 ~ 2698 [2008]